Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-03 · accession 0000950170-25-081198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-06-03 | 2025-06-03 | KYMR | Albers Jeffrey W. | Dir | S - Sale+OE | $49.00 | -6,349 | 0 | -100% | -$311.1K |
| DT | 2025-06-03 | 2025-06-03 | KYMR | Albers Jeffrey W. | Dir | M - OptEx | $10.34 | +6,349 | 6,349 | New | +$65.6K |
| DT | 2025-06-03 | 2025-06-03 | KYMR | Albers Jeffrey W. | Dir | M - OptEx | $0.00 | -6,349 | 5,000 | -56% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-03 | S | D | 6,349 | $49.00 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-03 | M | A | 6,349 | $10.34 | 6,349 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-06-03 | M | D | 6,349 | $0.00 | 5,000 | D | $10.34 · — to 2030-09-03 | 6,349 Common Stock | (F2) The shares underlying this stock option are fully vested and exercisable. |